Bromocryptin in the treatment of amenorrheas with hyperprolactinemia
Anselmo, J.
Revista Chilena de Obstetricia y Ginecologia 42(4): 248-255
1977
ISSN/ISBN: 0048-766X PMID: 616619 Document Number: 112876
Document emailed within 1 workday
Related Documents
Vasiukova, E.A.; Zefirova, G.S.; Ibragimova, G.V.; Mkrtumian, A.M.; Khaĭkina, M.B. 1979: Bromocryptin in the treatment of Itsenko-Cushing's disease Sovetskaia Meditsina 6: 65-69Muneyyirci-Delale, O.; Goldstein, D.; Reyes, F.I. 1989: Diagnosis of stress-related hyperprolactinemia. Evaluation of the hyperprolactinemia rest test New York State Journal of Medicine 89(4): 205-208
Garzarelli, S.; Cattaneo, A.; Nicorelli, G.; Carcheri, M.; Primi, I.; Vallerino, V. 1981: Clinical significance of prolactin in amenorrheas Minerva Ginecologica 33(4): 315-320
Morin, P. 1975: Physiological review and classification of amenorrheas La Revue du Praticien 25(19): 1399-1401
Gandar, R.; Collin, D. 1993: Functional hypothalamic amenorrheas. II. Clinical aspects Journal de Gynecologie Obstetrique et Biologie de la Reproduction 22(2): 133-140
Rebar, R.W. 1999: Following patients under treatment for hyperprolactinemia Journal of Reproductive Medicine 44(12 Suppl): 1100-1104
Rachev, E.; Spasov, S. 1985: Modern drug treatment of hyperprolactinemia Akusherstvo i Ginekologiia 24(6): 81-84
Felt, V.; Nedvídková, J. 1985: Use of dironyl in the treatment of acromegaly and hyperprolactinemia Vnitrni Lekarstvi 31(10): 980-985
Ovsiannikova, T.V.; Korneeva, I.E.; Speranskaia, N.V. 1991: Use of metergoline in the treatment of infertility associated with hyperprolactinemia Acta Universitatis Palackianae Olomucensis Facultatis Medicae 129: 157-162
Biller, B.M.; Luciano, A.; Crosignani, P.G.; Molitch, M.; Olive, D.; Rebar, R.; Sanfilippo, J.; Webster, J.; Zacur, H. 1999: Guidelines for the diagnosis and treatment of hyperprolactinemia Journal of Reproductive Medicine 44(12 Suppl): 1075-1084
Marek, J.; Bauer, J.; Srámková, J.; Hána, V. 1986: Terguride in the treatment of hyperprolactinemia and acromegaly Casopis Lekaru Ceskych 125(4): 100-105
Pakhomova, I.A.; Manuilova, I.A.; Afonina, L.I.; Nazarenko, T.A. 1984: Outcome of parlodel treatment in women with hyperprolactinemia Akusherstvo i Ginekologiia 5: 8-11
Mirakian, P.; Pugeat, M. 1990: Hyperprolactinemia. Physiopathology, diagnosis and principles of treatment La Revue du Praticien 40(24): 2297-2300
Tokhunts, K.A. 2007: Comparative evaluation of effectiveness of treatment of hyperprolactinemia Georgian Medical News 142: 14-19
Ruíz Velasco, V.; Rosas Arceo, J. 1979: Use of bromocryptin in the sterile female Ginecologia y Obstetricia de Mexico 46(273): 9-22
Schellen, T.M.; Declercq, A. 1978: Hyperprolactinemia, male impotence, oligozoospermia and the treatment with Bromocriptin Dermatologische Monatschrift 164(8): 568-570
Ovsiannnikova, T.V.; Pshchenichnikova, T.I.; Kovneeva, I.E. 1988: Various treatment regimens in infertility using bromoergocryptine in women with hyperprolactinemia Acta Universitatis Palackianae Olomucensis Facultatis Medicae 119: 557-561
García-Luna, P.P.; Leal-Cerro, A.; Astorga Jiménez, R. 1987: Current problems of hyperprolactinemia. II. Selection and systematization of the treatment Medicina Clinica 89(3): 122-127
Balabolkin, M.I.; Gerasimov, G.A.; Snigireva, R.I.; Gorokhova, T.R. 1989: Effectiveness of lysenyl-forte treatment in acromegaly and hyperprolactinemia syndrome Klinicheskaia Meditsina 67(9): 89-92
Barreca, T.; Gianrossi, R.; Gallamini, A.; Nizzo, M.C.; Queirolo, A. 1976: Endocrine effects of bromocryptin in patients with Parkinsonism Bollettino della Societa Italiana di Biologia Sperimentale 52(19): 1564-1567